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Objective. In this study, we evaluated changes in bone remodeling in an irradiated rat calvarial defectmodel according to duration of
hyperbaric oxygen therapy.Materials andMethods. The 28 rats were divided into four groups. Radiation of 12Gy was applied to the
skull, and 5-mm critical size defects were formed on both sides of the skull. Bone grafts were applied to one side of formed defects.
From the day after surgery, HBOwas applied for 0, 1, and 3 weeks. At 6 weeks after bone graft, experimental sites were removed and
analyzed for radiography, histology, and histomorphometry. Results. Micro-CT analysis showed a significant increase in new bone
volume in the HBO-3 group, with or without bone graft. When bone grafting was performed, BV, BS, and BS/TV all significantly
increased. Histomorphometric analysis showed significant increases in %NBA and %BVN in the HBO-1 and HBO-3 groups,
regardless of bone graft. Conclusion. Hyperbaric oxygen therapy was effective for bone regeneration with only 1 week of treatment.
1. Introduction
For treatment of head and neck tumors, radiation therapy
is used in conjunction with surgical resection for complete
tumor tissue killing. Irradiation uses ionizing radiation to
induce cell death by damaging the genes of fissionable cells,
which affects not only the tumor but also surrounding normal
tissue. In response to this tissue reaction, oral mucositis,
changes in taste, decreased salivation, radiation caries, and
radiation osteonecrosis may occur in the oral cavity [1].
Irradiation reduces the ability to regenerate bone within
the irradiation range [2]. Bone exposed to radiation is in
a hypocellular, hypovascular, hypoxic environment that is
unfavorable compared to the preirradiation condition for
bone regeneration or remodeling. Cumulative damage from
radiation is in the form of osteoradionecrosis (ORN) [3]. In
general, the higher the radiation dose, the higher the proba-
bility that radiation osteonecrosis will occur [4]. Trauma to
irradiated bone may also cause radiation necrosis [2]. The
most frequent causes of trauma are extraction, ulcers caused
by dentures, and periapical periodontitis [5]. In patients who
receive more than 65Gy of radiation, the likelihood of ORN
during extraction after irradiation is two times higher than
that in the preirradiation state [6].
Reconstruction of bone defects in patients who have
undergone radiation is an indispensable procedure for the
patient’s functional and aesthetic restoration. Reconstruction
of defects can restore function such as chewing, pronuncia-
tion, and swallowing; aesthetic improvement helps patients
return to their daily lives. However, patients who have under-
gone irradiation do not have complete natural healing due to
deficient bone-healing ability [1]. Therefore, in an impaired
osteogenic condition, hyperbaric oxygen therapy may be
combined with bone grafts to reconstruct defects [7, 8].
Hyperbaric oxygen therapy (HBO) is an adjunct therapy
to overcome impaired osteogenic conditions that affect bone
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Table 1: Study design.
Group Radiation Bone Graft Hyperbaric Oxygen
Positive control Graft side - O -
Nongraft side - - -
Negative control Graft side O O -
Nongraft side O - -
HBO-1 Graft side O O 1 week
Nongraft side O - 1 week
HBO-3 Graft side O O 3 weeks
Nongraft side O - 3 weeks
regeneration such as radiation [7, 8]. After a report that ORN
was treated with HBO [9], HBO has been used by many
clinicians as an adjunct treatment for ORN [10].
The anticipated effect ofHBO is reducing bone resorption
caused by hypovascularization by injecting oxygen at high
pressure to resolve the hypoxic state of the bone due to
poor vascularization [11]. Physiologically, the amount of
hemoglobin in the blood is fixed, so the supply of oxygen
is limited. However, since gas solubility is high in a high-
pressure state, oxygen can be directly transferred into plasma.
Theoretically, at 100% oxygen delivery at 2.5 ATA, oxygen
in the plasma can vary by about 17 times compared to 21%
oxygen at 1 ATA [12].This level can meet the oxygen demand
in the bone [12].
Hypoxia is a necessary process to initiate angiogenesis,
but a prolonged hypoxic state adversely affects the healing
process [13]. Persistent hypoxia inhibits fibroblast differen-
tiation, collagen synthesis, and granulation tissue formation
[3]. HBO contributes to the healing process by eliminating
hypoxia. In addition, HBO promotes alkaline phosphatase
activity during bone regeneration and HBO contributes
to osteoblast activity and angiogenesis upon distraction of
irradiated bone [14, 15]. The purpose of this study was to
evaluate the effect of HBO on the duration of hyperbaric
oxygen therapy in the presence or absence of bone graft.
2. Materials and Methods
2.1. Animals. This study used 28 healthy Sprague-Dawley rats
(8-week-old males). Animal selection, preparation, and sur-
gical protocols were conducted according to the Association
for Assessment andAccreditation of Laboratory Animal Care
guidelines and approved by the International Animal Care
and Use Committee (IACUC), Yonsei Medical Center, Seoul,
Korea (IACUC number 2013-0295-1). The animal laboratory
was set to 22∘C and 50% humidity with a 12-hour light-dark
cycle for experiments. Two rats were kept in each cage.
2.2. Experimental Procedures. Animals were classified into
four groups according to irradiation and HBO (n = 7): pos-
itive control, negative control, HBO-1, and HBO-3 (Table 1).
All experimental procedures were conducted under general
anesthesia through intraperitoneal injection of an anesthetic
cocktail of zolazepam  (Zoletil, 50mg/ml, 0.6ml/kg; Virbac
Lab. Carros, France) and xylaxine  (Rompun, 23.32mg/ml,
0.4ml/kg; Bayer Korea, Seoul, South Korea). Rats received
localized radiation with a single dose of 12.0Gy [16, 17]
to the calvarial area at 300 kV/12.5mA using X-RAD 320
(Precision X-Ray; North Branford, CT, USA) and field size
2 × 2 cm. At 4 weeks after irradiation, the calvarial site
was shaved before infiltration anesthesia. After exposing the
calvarial site, critical size defects were made bilaterally on a
sagittal suture (outer diameter 5.0mm) [17]. A critical size
defect is the smallest defect that does not completely heal
spontaneously in animals. In general, the critical size defect
for the rat calvarial is 8mm [18]. However, experiments show
that complete healing does not occur even at smaller defects,
and 5-mm [19, 20] and 4.6-mm [21] defects are also reported
as critical size defects.The right side received synthetic bone-
graftmaterial (OSTEON II Collagen;Genoss, Suwon, South
Korea), covered with a membrane (HA collagen membrane;
Genoss, Suwon, South Korea) [17, 22, 23]. On the left side,
the membrane was applied without a bone graft. Periosteum
and skin were sutured using 4-0 silk. Metacam  (1mg/kg,
once a day for 5 days; meloxicam, Boehringer Ingelheim,
Rhein, Germany) and baytril (10mg/kg/day, once a day for 5
days; Enrofloxacin , Bayer, Germany) were administered to
prevent infection and pain. The HBO-1 and HBO-3 groups
received HBO (2.4 ATA/day, for 6 day/week) for 1 week
and 3 weeks, respectively. HBO was gradually applied for 15
minutes under pressure and decompression and maintained
at 100% oxygen for 60 minutes at 2.4 ATA. All animals were
sacrificed after 6 weeks of bone grafting and surgical sites
were removed (Figure 1). Extracted specimens were fixed in
10% formalin for 7 days to prevent damage to the periosteum
and dura matter.
2.3. Microcomputed Tomography Analysis. After fixation 7
days, high-resolution microcomputed tomography (micro-
CT, Skyscan1173, Skyscan, Konitch, Belgium) was performed.
Specimens were photographed at 100 kV, 100 휇A, and pixel
size 8.17 휇m and analyzed by CTAn software (Skyscan,
Aartselaar, Belgium). Analysis was performed by separating
residual materials (RM; gray scale 135-255) and new bone
(NB; gray scale 90-135) (Figure 2) [17]. Volume of interest was
set to 5mm in diameter and 0.58mm in height. Bone volume
(BV;mm3), bone surface (BS;mm2) and bone surface density
(BS/TV; mm2/mm3) were analyzed for RM and NB.
2.4. Histologic and Histomorphometric Analysis. Fixed spec-
imens were embedded in paraffin after decalcification for 14
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Figure 1: Local irradiation and bone grafting procedure. (a) Field size of 2x2cm (see light window); (b) creating defect (Ø5.0); (c) membrane
covered after bone graft.
(a) (b) (c)
Figure 2: Gray scale of micro-CT analysis in surgical site. (a) Total bone (90-255); (b) residual material (135-255); (c) new bone (90-135).
days in 5% HCl. Paraffin blocks were serially sectioned at 5-
휇m thickness through the center of the defect in the coronal
plane of the sample. Slides were stained with hematoxylin
and eosin followed by light microscopy (BX50, Olympus Co.,
Tokyo, Japan).
Tissue specimens were processed at magnification 100
and digitized, and total augmented area (TAA; mm2),
residual material area (RMA; mm2), and connective tis-
sue area (CTA; mm2) were measured using Adobe Photo-
shop (Adobe Photoshop CS4, Mountain View, CA, USA).
Measured parameters were quantified using Scope EyE 3.6
(TOMORO, Samkyung Co., Seoul, Korea). Blood vessel
number counting was performed within the surgical site.
Each parameter was expressed as the percent residual mate-
rial area (%RMA; RMA/TAA∗100) and percent new bone
area (%NBA; NBA/TAA∗100), percent connective tissue area
(%CTA; CTA/TAA∗100), and percent blood vessel number
(%NBV; BNV/TAA∗100).
2.5. Statistical Analysis. Statistical analysis used IBM SPSS
23.0 (IBM Corp., Armonk, NY, USA) for radiographic and
histomorphometric data. Statistical analyses were between
positive and negative control groups, with statistical tests
between negative controls and experimental groups. Statisti-
cal analysis used the Kruskal-Wallis test followed by posttest-
ing using the Mann-Whitney test. The positive control and
negative control groupswere significantly different atP values
less than 0.05 and the negative control, andHBO-1 andHBO-
3 groupswere significantly different at P values less than 0.017.
Three experiments were performed to determine significance
levels (significance level = 5%/number of tests; 0.017 = 5%/3).
3. Results
3.1. Clinical Observations. A total of 9 animals died due to
side effects of general anesthesia after bone grafting. The
distribution was 3 rats in the positive control group, 3 in the
negative control group, and 3 in the HBO groups. No animals
died during the postoperative healing or HBO phases, and
the number of dead animals was made identical for further
experiments.
3.2. Microcomputed Tomography
3.2.1. Positive Control Group vs. Negative Control Group. No
significant differences in BV, BS, and BS/TV were detected
in graft material on the bone-grafted side. For the positive
control group, the BV of new bone was significantly higher
than for the negative control group (Table 2). No significant
differences were seen in BV, BS, and BS/TV of the new bone
from the nongrafted side (Table 3).
3.2.2. Negative Control Group vs. Experimental Group. No
significant differences were seen in BV, BS, and BS/TV in
residual material on the bone-graft side. However the BV of
new bone on the grafted side was significantly lower in the
negative control group than the HBO-3 group, and there was
no significant difference between HBO-1 and HBO-3 group
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Table 2: Volumetric analysis of grafted side in micro-CT (mean±SD). BV, bone volume (mm3); BS, bone surface (mm2); BS/TV, bone
surface density (bone surface/tissue volume; mm2/mm3); ∗ significant differences compared the positive control and negative control group;
† significant differences compared the negative control and HBO-1 group; ‡ significant differences compared the negative control and HBO-3
group.
Positive control Negative control HBO-1 HBO-3
Residual Material
BV 3.13 ± 1.36 3.34 ± 1.62 3.16 ± 0.51 3.57 ± 0.95
BS 149.59 ± 54.64 121.67 ± 42.71 126.52 ± 10.89 148.21 ± 29.04
BS/TV 12.53 ± 5.02 10.04 ± 3.64 10.19 ± 1.82 11.84 ± 2.70
New Bone
BV 2.72 ± 0.79 ∗ 1.93 ± 0.70 ∗‡ 2.5 ± 0.24 2.91 ± 0.31 ‡
BS 287.43 ± 65.50 244.47 ± 83.75 277.05 ± 24.01 307.72 ± 51.55
BS/TV 23.99 ± 6.47 20.15 ± 7.04 22.29 ± 3.77 24.56 ± 4.77
Table 3: Volumetric analysis of nongrafted side in micro-CT (mean±SD). BV, bone volume (mm3); BS, bone surface (mm2); BS/TV, bone
surface density (bone surface/tissue volume; mm2/mm3); ∗ significant differences compared the positive control and negative control group;
† significant differences compared the negative control and HBO-1 group; ‡ significant differences compared the negative control and HBO-3
group.
Positive control Negative control HBO-1 HBO-3
New Bone
BV 1.89 ± 1.02 0.82 ± 0.43 † 1.54 ± 0.32 † 1.34 ± 0.33
BS 180.96 ± 106.41 77.73 ± 49.88 † 152.09 ± 55.40 † 126.49 ± 37.41
BS/TV 15.50 ± 9.12 6.66 ± 4.27 12.80 ± 5.11 10.02 ± 2.97
(Table 2, Figure 3). Also, BS and BS/TV did not show any
significant difference between HBO-1 and HBO-3 (Table 2,
Figure 3). On the nonbone-grafted side, BV and BS of new
bone were significantly lower in the negative control than
in the HBO-3 groups (Table 3). There was no significant
difference between the HBO-1 and HBO-3 groups in BV, BS,
and BS/TV on the nongraft side.
3.2.3. Bone-Graed Side vs. Nongraed Side. In the positive
control group, the BS of the new bone was significantly
higher in the bone-grafted side than in the nongrafted
side (Figure 3(b)). The BV, BS, and BS/TV values of the
bone-grafted side were significantly higher in other groups
(Figure 3).
3.3. Histological Analysis. In the defect margin region of
grafted side, the growth pattern and distance of newly formed
bone were higher in the positive control group than in the
negative control group (Figures 4(a) and 4(c)). At the center
of the defect region, noticeable new bone formation was
observed in the positive control group and HBO-3 group
(Figures 4(b) and 4(h)). New bone formation in groups
increased in the order: negative control, HBO-1, and HBO-
3, positive control (Figures 4(c)–4(h)). In the positive control
group, almost no new bone was seen, but in the HBO-
1 group, osteoclasts were observed with new bone. Island-
shaped immature woven bone was clearly observed in the
HBO-3 group (Figure 4(h)).
3.4. Histomorphometric Analysis
3.4.1. Positive Control Group vs. Negative Control Group.
On bone-graft sides, %NBA was significantly increased in
the positive control group and %RMA was significantly
decreased (Table 4). On the nonbone-graft site, the positive
control group had a significantly higher %NBA than the
negative control group, while %CTA was significantly lower
(Table 5).
3.4.2. Negative Control Group vs. Experimental Group. On
the bone-grafted side, %NBA and %BVN were significantly
lower in the negative control group than in the HBO-1 and
HBO-3 groups (Table 4). On the nongrafted side, %NBA and
%BVNwere significantly higher in theHBO-1 group than the
negative control group (Table 5).
3.4.3. Bone-Graed Side vs. Nongraed Side. The positive
control group had a significantly higher %NBA on the
nongrafted side than on the bone-grafted side (Figure 5(a)).
In the negative control group, %NBA and %CTA were
significantly higher in the nongrafted side (Figures 5(a)
and 5(b)). In the HBO-1 and HBO-3 groups, %NBA values
were higher on the nongrafted side, but the difference was
not significant (Figure 5(a)). For the HBO-3 group, %CTA
was significantly higher on the nongrafted side and %BVN
showed no significant difference among groups but was
higher on nongrafted sides (Figures 5(b) and 5(c)).
4. Discussion
Radiotherapy and surgical resection are performed for the
treatment of head and neck tumors and bone regeneration
ability of treatment sites is reduced by radiation therapy [2].
After surgical resection, bone grafting is performed to induce
bone regeneration. However, bone grafting alone may have
limitations in tissues in which the bone regeneration ability is
reduced due to irradiation.This study investigated the effects
of HBO on HBO duration and the presence or absence of
bone graft.
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Table 4: Histomorphometric analysis of grafted side (mean±SD). %NBA, percent new bone area (new bone area/total area; mm2); %RMA,
percent residualmaterial area (residualmaterial area/total area;mm2);%CTA, percent connective tissue area (connective tissue area/total area;
mm2); %BVN, percent blood vessel number (blood vessel number/total area; 1/mm2); ∗ significant differences compared the positive control
and negative control group; † significant differences compared the negative control and HBO-1 group; ‡ significant differences compared the
negative control and HBO-3 group.
Positive control Negative control HBO-1 HBO-3
%NBA 14.94 ± 7.99 ∗ 0.68 ± 0.42 ∗†‡ 10.83 ± 15.43 † 7.89 ± 6.66 ‡
%RMA 21.12 ± 11.25 ∗ 37.02 ± 16.23 ∗ 13.84 ± 5.27 19.31 ± 12.58
%CTA 63.94 ± 8.44 62.31 ± 16.45 75.33 ± 16.24 72.80 ± 9.91
BVN ratio 8.64 ± 10.99 3.76 ± 7.73 †‡ 23.06 ± 9.60 † 25.87 ± 23.06 ‡
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Figure 3: Grafted side and nongrafted side analysis in micro-CT. (a) BV, bone volume in new bone (mm3); (b) BS, bone surface in new bone
(mm2); (c) BS/TV, bone surface density in new bone (mm2/mm3).
Comparing the positive control and negative control
groups, micro-CT and histomorphometric analysis in grafted
side showed that new bone formation was significantly
reduced by irradiation. By histomorphometry analysis,
remaining grafts were fewer in the positive control group.
Micro-CT analysis showed no significant difference in resid-
ual materials, but bone volume was less and bone surface
was greater in the positive control group than the negative
control group.This result indicated that bonemetabolismwas
more active in the positive control group. In the defectmargin
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Table 5: Histomorphometric analysis of nongrafted side (mean±SD). %NBA, percent new bone area (new bone area/total area;mm2); %CTA,
percent connective tissue area (connective tissue area/total area; mm2); %BVN, percent blood vessel number (blood vessel number/total area;
1/mm2); ∗ significant differences compared the positive control and negative control group; † significant differences compared the negative
control and HBO-1 group; ‡ significant differences compared the negative control and HBO-3 group.
Positive control Negative control HBO-1 HBO-3
%NBA 33.12 ± 13.12 ∗ 4.58 ± 3.80 ∗† 13.01 ± 5.15 † 15.44 ± 13.75
%CTA 66.88 ± 13.12 ∗ 95.42 ± 3.80 ∗† 86.99 ± 5.15 † 84.56 ± 13.75
BVN ratio 9.23 ± 12.05 12.43 ± 9.43 † 40.14 ± 24.63 † 50.45 ± 83.78
(a) (b) (c)
(d) (e) (f)
(g) (h)
Figure 4: Histological analysis (H-E staining, x200). Scale bar = 200휇m. (a, b) Positive control group; (c, d) negative control group; (e, f)
HBO-1 group; (g, h) HBO-3 group. Arrowheads, mature bone; arrow, immature woven bone.
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Figure 5: Grafted side and nongrafted side analysis in histomorphometry. (a) %NBA, percent new bone area (mm2); (b) %CTA, percent
connective tissue area (mm2); (c) %BVN, percent bleed vessel number (mm2).
region, the positive control group actively formed immaturely
woven bone, but the negative control group did not. The
results of this study confirmed existing results that radiation
irradiation significantly degrades bone regeneration ability
[2] and we consider that the development of animal models
for radiation has been successful.
Comparing the negative control group and experimen-
tal groups, the amount of bone formation increased with
application of HBO. Micro-CT analysis showed significant
differences between the negative control and HBO-3 for BV
for new bone, with small differences between the HBO-1
and HBO-3 groups. By histomorphometry analysis, residual
material was mostly found in the negative control group,
with least in the HBO-1 group. No significant difference was
observed between theHBO-1 andHBO-3 groups for any data.
These results suggested that HBO was effective in reducing
bone loss due to radiation therapy.HBOduration of oneweek
was sufficient.
When bone-grafted and nongrafted sides were compared,
the amount of bone formation was significantly higher on the
nongrafted than on the grafted side in histomorphometric.
BCP is an osteoconductive material that only fills defect
8 BioMed Research International
volume and does not induce substantial new bone formation.
Previous reports showed no significant difference in the
amount of new bone when using synthetic bone grafts [24,
25]. However, in this study, significant differences were found
in most analyses. HA-coated collagen membranes were used
in this study, but the use of amembranewithout graftmaterial
on the nongraft side seemed to show effects of guided tissue
regeneration. Since guided tissue regeneration induces bone-
defect healing, bone was actively made in defects without
graft material. In addition, osteoconductive material that
does not induce osteoinduction in defects with decreased
healing potential after radiation appeared to interfere with
bone regeneration. The addition of a procedure to apply a
graft to defectsmay lower natural healing potential. However,
the success of oral and maxillofacial implants indicates that
the presence of sufficient bone at the implant site is the most
important factor. Therefore, using osteoconductive material
alone to maintain bone volume would be meaningful, even
if the rate of new bone formation is slow. In this study,
micro-CT showed that bone regeneration on bone-grafted
sides was significantly more active in all groups. Conversely,
histomorphometry showed no significant differences, but all
groups had more bone regeneration on nongrafted sides.
However, considering histomorphometry showed no sig-
nificant differences, it may be regarded as a limited two-
dimensional evaluation. Considering these limitations, eval-
uation by three-dimensional bone analysis is indispensable.
This study evaluated the effect of radiation on bone
regeneration in rat calvarial defects of critical size according
to HBO duration. In clinical situations, graft material is
used to maintain bone-defect volume. Therefore, BCP was
applied to defects. Grafted sides showed less new bone for-
mation than nongrafted side. New bone formation increased
in groups treated with HBO. In situations where clinical
healing potential is reduced, HBO seemed to overcome the
disadvantageous bone performance of bone-graft materials.
In this study, the sacrifice time of the hyperbaric oxygen
group was the same.
The initial effect of HBO was not evaluated, which is a
limitation of this study. In a further study, analyzing bone
metabolism markers to assess bone remodeling according to
HBO timingmight confirmHBOeffects on bone remodeling.
HBO was evaluated to be effective for bone regeneration
in bone tissue with reduced regenerative capacity due to
irradiation. In addition, new bone formation with HBO
increased in proportion toHBOduration, but was considered
to be effective for bone regeneration only with HBO applica-
tion for one week.
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